Previous close | 0.3500 |
Open | 0.3500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 20.00 |
Expiry date | 2024-08-16 |
Day's range | 0.3500 - 0.4500 |
Contract range | N/A |
Volume | |
Open interest | N/A |
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, announced today that its Board of Directors has approved a share repurchase program to repurchase up to $100 million of its common stock. This follows the program that was previously announced on February 29, 2024. The program will be funded through available cash balances. Shares may be repurchased through open market repurchases, including
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Progyny’s executives will participate in a fireside chat at the BofA Securities 2024 Healthcare Conference on Wednesday, May 15, 2024, at 5:00 P.M. Pacific Time / 8:00 P.M. Eastern Time. They will also participate in a fireside chat at the Leerink Partners Healthcare Crossroads Conference 2024 on Wednesday, May 29, 2024,
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...